1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Demographic data on the study patients
Patient No./Age (y)/Sex Pathologic Diagnosis (Grade of Gliomas, 1–4) Diagnostic Method rTPmax mADC ×10−3 mm/s2 1/41/M 2 Biopsy 1.01 0.92 2/51/M 4 Surgery 1.55 0.89 3/29/M 2 Surgery 1.05 1.23 4/30/F 2 Biopsy 1.27 1.16 5/42/F 4 Surgery 1.59 0.71 6/41/M 3 Surgery 1.29 0.98 7/45/M 4 Biopsy 1.62 0.43 8/43/F 3 Surgery 1.32 0.68 9/30/F 2 Surgery 0.97 0.94 10/32/M 2 Surgery 1.13 1.24 11/35/F 4 Surgery 2.25 0.92 12/41/F 3 Surgery 1.23 0.78 13/42/M 4 Biopsy 1.93 0.72 14/40/M 3 Surgery 1.29 0.84 15/32/M 2 Surgery 1.28 1.45 16/46/F 4 Surgery 1.80 1.06 17/39/F 4 Surgery 2.24 0.88 18/52/M 3 Biopsy 1.29 0.87 19/42/M 4 Surgery 1.43 0.74 20/35/F 2 Surgery 0.89 1.22 21/39/M 4 Surgery 1.56 0.76 22/30/F 3 Surgery 1.26 0.78 23/40/F 4 Surgery 1.43 0.59 24/42/M 2 Surgery 1.24 1.15 25/52/M 4 Biopsy 1.66 0.88 26/45/F 3 Biopsy 1.26 0.69 27/42/M 4 Surgery 1.29 0.69 28/37/F 2 Surgery 1.11 1.28 29/50/M 2 Surgery 1.01 1.01 30/51/M 4 Biopsy 1.44 0.72 31/29/M 2 Surgery 1.17 1.15 32/51/F 4 Surgery 1.30 0.84 33/67/M 4 Surgery 1.32 0.94
Note:—rTPmax indicates ratio of maximum tumor perfusion signal intensity; mADC, minimum apparent diffusion coefficient value.